Our corporate philosophy is 'Client satisfaction comes first' and mission is to provide the solutions and services based on that.

We are a software service provider who implements the solutions for collecting clinical data. There are the huge number of drugs approved yearly. On average, it takes at least ten years for a new medicine and costs enormously to complete the journey from initial discovery to the marketplace. We propose the cost-effective solutions that can streamlines your clinical data in an efficient way.

 
Company NameClinCloud Ltd.
Foundation12th September, 2014
Location 2nd Floor PMO Nihonbashi Oedodori, 1-5 Nihonbashi Kodenma, Chuo-ku, Tokyo, Japan 103-0001
Tel03-3510-2640
RepresentativeCEO Jiro Kosaka
Capital355,000,010 yen
BanksSumitomo Mitsui Banking.
Mizuho Bank, Ltd.
Japan Finance Corporation.

Philosophy

We utilize cutting-edge technologies and solutions that were built for the pharmaceutical industry ‘s needs, supported by our health science professional staff. We provide services along with the corporate policy “Customer service is most important”. In order to achiever client’s purpose effectively, we collaborate with partner companies to provide seamless and broad services.

Services

We provide cutting-edge technologies and solutions that were built for the pharmaceutical industry ‘s needs for Japan and global. Our experience and professional staff serve all the support needs in a timely manner, which can certainly optimize the efficiency of business processes and reduce costs in an effective way. We provide services along with the corporate policy “Customer service is most important”. In order to achiever client’s purpose effectively, we collaborate with partner companies to provide seamless and broad services.

・Proposing with our partner CROs
・CSV consultation
・On-site audit support
・Set-up EDC/ePRO
・Validations
・Set-up trainings / Train the trainer
・EDC /ePRO consultaiton
・Translation and Validation of ePRO questionnaires
・Devise Rental Service ( with our partner CRO)
・Supporting UAT planning / UAT runs
・Introducing IWRS / Consultation
・Simulation of minimization
・Hosting

Our Experiences

We as the leading EDC vendor have been increasing a track record of implementations in Japan and globally over four hundred of studies with Enterprise Cloud. JPMS and consolation services.

Our experiences by phase

Clinical Research / Observational Study
Investigator Initiated Study
Phase I
Phase II
Phase III
Phase Ⅳ
PMS
Registry

Our Experiences by therapeutic

Tumor Cancer
Central Nervous
Cardiovascular
Orthopedic
Sensory Organ
Respiratory
Gynecology
Digestive Organs
Immune
Allergy
Devise
Infections
Sensory Tract

Message

ClinCloud utilizes cutting-edge technology and solutions that meet the needs for the pharmaceutical industry, supported by our health science professional staff. along with the corporate policy “Customer service is most important”. Consulting the customers effectively to achieve objectives, we collaborate with partner companies to provide scrupulously broad services in dept. ClinCloud has been founded in October 2014 as to help the pharmaceutical industry by utilizing innovative and cutting-edge solutions in the IT industry, along with the corporate motto “Customer service is most important”. Setting up the company, the corporative supports for all the set-up activities given by a number of people were sincerely appreciated. Japan Pharmaceutical Manufacturers Association(JPMA) has announced “Guidance for Electric Data in Clinical Trials “ and the use of EDC has become popular. In near future, the EDC will be continuously spread out in the market. ClinCloud proposes to utilize cutting-edge technology and solutions in the IT industry which are extraordinary intuitive and high-speed in response, enabling to stable and solid environments. ClinCloud commits to our corporate philosophy “Pursuing customer’s satisfactions, meeting needs and flexibly proving the best of breed solution and services!”. ClinCloud would endeavor to be a trustworthy vendor.

Best Regards,

CEO, Jiro Kosaka

Organization

Board of Directors

Representative Director, CEOJiro Kosaka
Representative DirectorTsubasa Iwata